Laurus Labs receives USFDA approvals for two ANDAs under PEPFAR
These approvals enable Laurus Labs to launch both the products in several LMIC markets
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Laurus Labs
Laurus Labs’ PAT touches Rs 110 crore in Q4
The consolidated revenue for the quarter was up by 32 per cent to Rs 839 crore as against Rs 635 crore in Q4 FY'19, a press…
While the market is bleeding, pharma sector has withstood the lock-down. Can it be a good bet for…
Rahul Agarwal, Director, Wealth Discovery, explains how the once beaten-down sector, has recently witnessed sharp uptick with…
Laurus Labs and Rising Pharma to collaborate on a clinical trial for preventive COVID-19 treatment
They will work with University of Minnesota to explore hydroxychloroquine as preventive treatment for coronavirus disease 2019
Laurus Labs to acquire Aspen Pharmacare’s subsidiary company
The transaction will provide to the company access to the South African public antiretroviral (ARV) sector, which manages the…
Laurus Labs receives EIR from US FDA for Visakhapatnam units
The company has also received approval from the Global Fund (GF) expert review panel for its fixed dose combination, TLE 400, for…
Laurus Labs’ distribution partner Rising Pharmaceuticals launches Pregabalin Capsules in US market
Pregabalin Capsules and had US sales of approximately $5,497 million for the 12 months ending March 2019, according to IMS Health
Laurus Labs completes US FDA audit for Unit 4
The inspection was carried out from July 8 to 12 July 2019 Laurus Labs, a leading research and development-driven and…
Lauras Labs’ CEO gifts Rs 1.5 crore grant to ISB
Dr Satyanarayana Chava is an alumnus of the ISB's founding PGPMAX class An alumnus of the the Hyderabad-based Indian School of…
Pharmexcil organises series of initiatives during CPhI Japan
Brand India Pharma was strongly represented by Indian pharma companies at various platforms